Our data suggest that PTPRT could be a drug target for obesity, because Ptprt−/− mice resist many key effects of a high-fat diet, including increased body mass, hyperglycemia, hypercholesterolemia, insulin resistance and increased adiposity. The gene discussed is PTPRT; the disease is familial hypercholesterolemia.